UnitedHealth Group (NYSE: UNH) reported Q2 EPS of $4.70, $0.27 better than the analyst estimate of $4.43. Revenue for the quarter came in at $71.3 billion versus the consensus estimate of $69.45 billion.

“The compassion, dedication and ongoing efforts of our 330,000 colleagues to advance peoples’ health and health system performance reinforces our confidence in delivering strongly on our strategies for those we serve and continuing to grow well into the future,” said Andrew Witty, chief executive officer of UnitedHealth Group.

GUIDANCE:

UnitedHealth Group raises FY2021 EPS of $18.30-$18.80, versus the consensus of $18.57.

For earnings history and earnings-related data on UnitedHealth Group (UNH) click here.